IMFINZI® Regimen Boosts Survival in Muscle-Invasive Bladder Cancer: NIAGARA Phase III Post-Hoc Analysis A post-hoc exploratory analysis from the Phase III NIAGARA trial has shown that AstraZeneca’s IMFINZI® (durvalumab), when…
Sigma Healthcare Merges with Chemist Warehouse Sigma Healthcare has officially merged with Chemist Warehouse Group (CW), marking a monumental moment for both companies. As of today, the newly merged entity’s…
Pro Medicus Limited Q2 Results Leading health imaging company Pro Medicus Limited (ASX: PME) reported a strong financial performance for the first half of the 2024 fiscal year, posting a…
Superior HealthPlan Named Best Place for Working Parents® in Texas Superior HealthPlan, a prominent managed care organization in Texas and a subsidiary of Centene Corporation (NYSE: CNC), has been named…
QIAGEN Expands Bioinformatics Leadership with New Data Center in Asia-Pacific QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has officially opened a new data center in Melbourne, Australia, reinforcing its leadership…
CareDx to Present AlloHeme Data at 2025 Tandem Meetings on Early Relapse Detection CareDx, Inc. (Nasdaq: CDNA), a leader in precision medicine focused on transplant patients and caregivers, today announced…
Clinical Study Confirms Lubrizol MAGSHAPE™ Enhances Magnesium Absorption Lubrizol’s MAGSHAPE™ microcapsules, a micronized and microencapsulated form of magnesium, have been found to significantly improve magnesium absorption compared to other commonly…
Dignity Health Enhances Community Ties with Bakersfield Arena and Venue Partnership The City of Bakersfield, California, has partnered with Dignity Health to expand their naming-rights agreement for one of the…
Patient Safety Excellence: IHI and DAISY Foundation Honor Exceptional Nurses The Institute for Healthcare Improvement (IHI) and The DAISY Foundation have revealed the winners of the prestigious DAISY Award® for…
Access Vascular Catheters with MIMIX® Tech Added to Recon Supply’s Federal Contract Access Vascular, Inc. (AVI), a leader in addressing critical vascular access challenges through its innovative hydrophilic biomaterial technology,…
New Interactive Storybook Educates Children on Rare Kidney Disease Through Adventure Alexion, AstraZeneca Rare Disease has introduced a new electronic storybook designed to help children living with atypical Haemolytic Uraemic…
Charles River and Deciphex Expand Partnership to Enhance Digital Pathology with Exclusive Image Management Solutions Charles River Laboratories (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, have announced…